|
TRIM25 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.760400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.446030E-01 |
| Normal-vs-Stage2 |
6.745000E-01 |
| Normal-vs-Stage3 |
4.402800E-01 |
| Normal-vs-Stage4 |
9.542200E-01 |
| Stage1-vs-Stage2 |
6.518400E-01 |
| Stage1-vs-Stage3 |
1.087550E-01 |
| Stage1-vs-Stage4 |
5.324000E-01 |
| Stage2-vs-Stage3 |
3.450400E-01 |
| Stage2-vs-Stage4 |
7.409400E-01 |
| Stage3-vs-Stage4 |
6.518000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.327960E-01 |
| Normal-vs-AfricanAmerican |
1.214580E-01 |
| Normal-vs-Asian |
1.951780E-01 |
| Caucasian-vs-AfricanAmerican |
7.206400E-01 |
| Caucasian-vs-Asian |
1.220070E-02 |
| AfricanAmerican-vs-Asian |
8.704700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.633800E-01 |
| Normal-vs-Female |
2.523200E-03 |
| Male-vs-Female |
9.015600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.262950E-01 |
| Normal-vs-Extreme_Weight |
5.713800E-01 |
| Normal-vs-Obese |
9.621900E-02 |
| Normal-vs-Extreme_Obese |
3.378600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.045900E-02 |
| Normal_Weight-vs-Obese |
9.393000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.884600E-01 |
| Extreme_Weight-vs-Obese |
4.256000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.712200E-01 |
| Obese-vs-Extreme_Obese |
9.510000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.072000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.933830E-02 |
| Normal-vs-Age(61-80Yrs) |
3.808200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.757800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.579000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.962620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.083800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.601640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.135600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.653000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.654300E-02 |
| Normal-VS-Type2 PRCC |
5.039800E-01 |
| Normal-VS-KIRP CIMP |
3.831600E-02 |
| Normal-VS-Unclassified PRCC |
3.722400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.318080E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.312420E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.883190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.198300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.816300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.686000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.182800E-01 |
| Normal-vs-N1 |
3.487200E-01 |
| Normal-vs-N2 |
8.246000E-01 |
| N0-vs-N1 |
1.026840E-01 |
| N0-vs-N2 |
7.479000E-01 |
| N1-vs-N2 |
6.002600E-01 |
|
|
